Product Information
DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.4952 per EA under NDC 43975028110. Its NADAC has been published 315 times since Aug 12, 2020.
FDA first approved this application on Jan 22, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 25 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
43975028110
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE DL-ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA205401FDA Approved
1/22/2019
TE Code
AB1
On Market Since
3/16/2020
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 315 times since Aug 12, 2020, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4952 per EA |
|---|---|
| All-time high | $1.1343 (Sep 16, 2020) |
| All-time low | $0.4173 (May 22, 2024) |
| 52-week high | $0.5709 |
| 52-week low | $0.4896 |
| Median price | $0.5944 |
| Average price | $0.6178 |
| Largest weekly change | +30.3% (Dec 18, 2024) |
| Weeks tracked | 315 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by ANI Pharmaceuticals, Inc., is $0.4952 per EA (NDC 43975028110), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has declined 50.0%. It has been tracked across 315 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?
Since Aug 12, 2020, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $1.1343 (Sep 16, 2020), with a median of $0.5944 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHET ER 25 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?
DEXTROAMP-AMPHET ER 25 MG CAP (NDC 43975028110) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.